Zaffanello Marco, Bassareo Pier Paolo, Cataldi Luigi, Antonucci Roberto, Biban Paolo, Fanos Vassilios
Section of Pediatrics, Department of Life and Reproduction Sciences, University of Verona, Piazzale L. Scuro 10, Verona, Italy.
J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:87-9. doi: 10.3109/14767058.2010.501156.
Several drugs have been shown to produce an adverse affect on kidneys, mainly when exposure occurred during active nephrogenesis (pregnancy or prematurity). Several experimental studies on drug-related renal injury have been done on animal models. Observational reports on early drug-related nephrotoxicity in humans are increasing. The investigations regard nephrotoxicity from antibiotics (particularly aminoglycosides), angiotensin-converting enzyme (ACE) inhibitors, non-steroidal anti-inflammatory drugs and antifungins. Few reports have been specifically on the long-term effects on kidneys of drugs given to newborns during active nephrogenesis. Most observations were targeted to investigate long-term renal effects of prematurity and intrauterine growth retardation (IUGR). Nephrotoxic medication taken during fetal life and during postnatal nephrogenesis could interfere with nephron generation contributing to a particular magnitude of damage. Such adjunctive damage could further increase the risk of renal failure in the adulthood of children born prematurely.
已有几种药物被证明会对肾脏产生不良影响,主要是在肾发生活跃期(孕期或早产期)接触这些药物时。已在动物模型上进行了多项关于药物相关性肾损伤的实验研究。关于人类早期药物相关性肾毒性的观察报告也在增加。这些研究涉及抗生素(尤其是氨基糖苷类)、血管紧张素转换酶(ACE)抑制剂、非甾体抗炎药和抗真菌药的肾毒性。关于在肾发生活跃期给予新生儿的药物对肾脏长期影响的具体报告很少。大多数观察旨在研究早产和宫内生长受限(IUGR)的长期肾脏影响。胎儿期和出生后肾发生期服用的肾毒性药物可能会干扰肾单位的生成,造成一定程度的损害。这种附加损害可能会进一步增加早产儿童成年后患肾衰竭的风险。